Experimental Hematology & Oncology

Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma

Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma

Methylome of human senescent hematopoietic progenitors

A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Understanding metabolic changes in aging bone marrow

Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation

The association of HLA-C alleles with multiple myeloma in Chinese patients

A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma